John Lehmann, Director of Business Development, IMARC
Clinical research professionals need to keep up to date with changes to the industry to ensure their studies remain compliant and human subjects are protected as research becomes more complex. Several important changes have taken place over recent years, including greater emphasis on risk-based and quality-focused thinking, as well as the increased use of electronic technologies to accomplish research activities.
Paper-based studies are now the exception to studies conducted with electronic case report form (eCRF) systems, electronic medical records (EMR) are nearly ubiquitous, many research systems are moving to the cloud, and patient-centered study designs are more common with the rising use of mobile technology.
IMARC Research understands the importance of staying informed as research evolves, and has prepared this new whitepaper to highlight and summarize changes in key areas.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.